Global Motion Sickness Drugs Market Insights, Forecast to 2025

SKU ID : QYR- 13803753

Publishing Date : 14-Aug-2019

No. of pages : 117

PRICE
3900
7800


  • Motion Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
    The global Motion Sickness Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Motion Sickness Drugs market based on company, product type, end user and key regions.

    This report studies the global market size of Motion Sickness Drugs in key regions like North America, Europe, China and Japan, focuses on the consumption of Motion Sickness Drugs in these regions.
    This research report categorizes the global Motion Sickness Drugs market by top players/brands, region, type and end user. This report also studies the global Motion Sickness Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

    The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    GlaxoSmithKline
    Prestige Brands
    WellSpring Pharmaceutical Corporation
    Baxter International
    Mylan
    Sandoz
    Pfizer
    Myungmoon Pharm
    Caleb Pharmaceuticals

    Motion Sickness Drugs market size by Type
    Anticholinergic
    Antihistamines
    Others

    Motion Sickness Drugs market size by Applications
    Adults
    Children

    Market size by Region
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Central & South America
    Brazil
    Middle East & Africa
    Turkey
    GCC Countries
    Egypt
    South Africa

    The study objectives of this report are:
    To study and analyze the global Motion Sickness Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Motion Sickness Drugs market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Motion Sickness Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Motion Sickness Drugs submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    In this study, the years considered to estimate the market size of Motion Sickness Drugs are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

    This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Motion Sickness Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.